Bill Trimble
Analyst · Citigroup. Please go ahead
Thanks, Darrell, and good morning. I would like to begin by highlighting the company's achievements in the third quarter of 2017. This quarter we announced and closed on 169,000 square foot FBI field office located in Salt Lake City, Utah. The Class A LEED Gold certified, four-storey, single tenant facility is located on a 7.5 acre campus and overseas federal operations in all of Utah, Idaho and Montana. FBI Salt Lake City is one of 56 FBI field offices strategically located throughout the United States and serves as a regional headquarters directing 18 satellite offices also known as resident agencies located throughout Utah and the two surrounding states. The built-to-suit construction was completed in 2012 and is 100% occupied by the FBI through October 20, '32 for initial non-cancelable least term of 20 years. Upon closing of this important government occupied facility, Easterly government properties now owns seven of the 56 FBI field offices, thus making Easterly the single, largest private owner of FBI field offices in the country. As we mentioned on prior calls, Easterly is also under contract to acquire a VA outpatient facility that is located just outside South Bend, Indiana. The outpatient facility is now complete and is seeing local veterans on a daily basis. We expect to close on this property in the coming quarters and look forward to welcoming this highly important mission critical facility into our growing portfolio. As a reminder the VA South Bend outpatient clinic is very similar to VA Loma Linda but on smaller scale of 86,000 square feet. The outpatient facility is leased to the VA for an initial 15-year non-cancelable term. Once the VA South Bend acquisition is complete, Easterly will own two new state of the art Class A VA outpatient facilities totaling a combined 414,000 square feet of leased space well backed by the full facing credit of the U.S. government. While on the topic of the VA, the nearly 328,000 square foot Loma Linda outpatient care center has had its first full quarter of operations under Easterly's ownership and we are pleased to report everything is going well in the state of the art Class A facility. In fact, our asset management team recently received a number of requests from the VA to make tenant funded enhancements valued at over $1.5 million, to this almost brand new facility. Our asset management team is doing a wonderful job of addressing the needs of our tenants and at quarter end they are managing 16 active value enhancing tenant funded projects across the portfolio. Turning to development. Mike Ibe and his team have made meaningful strides in building the pipeline of development opportunities that we expect will serve us well for the next several years. Development opportunities are not only accretive as we add real value to both the government and their shareholders, but they also give us longer-valuable leases many being 20 years in duration, which can provide earnings stability and additional opportunities to be opportunistic in managing our liabilities. As you may recall, we have two active development projects underway both to be occupied by the FDA. The first is a 70,000 square foot laboratory located in Alameda, California. We are pleased to report that we have completed the initial demolition of the current site and now have all [self] [ph] permits and the first stage TI permits in hand. We are working hand in hand with the GSA and FDA to incorporate some design changes to make sure that the facility functions to the highest and best use of tenant agency. The estimated completion date of this project is the first quarter of 2019. The second laboratory located in Lenexa, Kansas, just outside of Kansas City, is roughly 53,000 square feet and we are currently finalizing the design intention drawings. We anticipate an early third quarter 2019 completion for this laboratory. Upon completion of these two facilities, two brand new non-cancellable 20-year leases will commence. Our acquisition team is constantly sourcing new, high quality opportunities that mirror our average portfolio building size and drive FFO growth. We have a robust pipeline of bulls eye opportunities that fall within the $20 million to $40 million acquisition range and remain in constant contact with developers looking to sell properties so that they can move on to their development project. To reiterate, our target market includes buildings leased to a single tenant of U.S. federal government. They are often the result of a design build award and are usually over 40,000 square feet in size. If a building of this nature is occupied by the right tenant, fulfilling the right mission and meets the traditional real estate underwriting requirements, then we will evaluate a potential acquisition. These bulls eye elements are very important from a re-leasing perspective as we look to achieve renewal rates at an increase in the high-teens to low 20s. Finally, to summarize our acquisition and development activities since the third quarter of 2016, we have acquired five new assets, soon to be six, adding 700,000 square feet to the portfolio. We welcome two new tenant agencies to the portfolio, the VA and OSHA and we have our grown our relationship with exiting tenant agencies like the U.S. Courts and the FBI. We were awarded the development rights for brand new state of the art FDA laboratory in Lenexa, Kansas, marking two active development projects for the company. Through this growth we have reduced the age of our portfolio and extended the average remaining lease term despite progression of time working against us. As the company's CEO, I am quite proud of all we have accomplished in the past year. With that, I will now turn the call over to Meghan for a discussion of the quarterly results and earnings guidance.